000	00000nam 2200000zi 4500
001	9.908429
003	CaOODSP
005	20221107181645
006	m     o  d f
007	cr cn|||||||||
008	220223t20212022qucabd  o    f000 0 eng d
020	|a9780660422022
040	|aCaOODSP|beng|erda|cCaOODSP
043	|an-cn---
086	1 |aH139-37/2022E-PDF
100	1 |aGilbert, Marie-Line, |eauthor.
245	10|aAt-a-glance : |bthe emergence of nitazenes and brorphine in Canada since 2019 : a working group report / |cMarie-Line Gilbert, Michèle Boileau-Falardeau, Cindy Leung Soo, Luc Chicoine, Michael Bushey, Vincent Marleau, Cathy Copeland, Christian Gagne, Thomas Berrigan.
246	10|aEmergence of nitazenes and brorphine in Canada since 2019 : |ba working group report
264	1|aLongueuil, QC : |bHealth Canada Drug Analysis Service : |bRoyal Canadian Mounted Police : |bCanada Border Services Agency, |c2021.
264	4|c©2022
300	|a1 online resource (9 pages) : |billustrations, maps, graphs
336	|atext|btxt|2rdacontent
337	|acomputer|bc|2rdamedia
338	|aonline resource|bcr|2rdacarrier
500	|aCover title.
500	|aIssued also in HTML format.
500	|aIssued also in French under title: Survol : la présence de nitazènes et de brorphine au Canada depuis 2019 : rapport du groupe de travail.
520	|a"This report aims at presenting the result of a pilot project based on a collaborative work between the DAS, the Canada Border Services Agency (CBSA) and the Royal Canadian Mounted Police (RCMP) related to nitazenes and Brorphine in order to draw a more complete picture of the situation in Canada"--Goal & Focus, page 2.
650	0|aOpioids.
650	0|aBenzimidazoles|zCanada.
710	1 |aCanada. |bHealth Canada. |bDrug Analysis Service, |eissuing body.
710	2 |aRoyal Canadian Mounted Police, |eissuing body.
710	2 |aCanada Border Services Agency, |eissuing body.
775	08|tSurvol : |w(CaOODSP)9.908430
856	40|qPDF|s1.25 MB|uhttps://publications.gc.ca/collections/collection_2022/sc-hc/H139-37-2022-eng.pdf
856	4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/publications/healthy-living/emergence-nitazenes-brorphine-canada-2019.html
986	|a210669